Solu

Solu, founded in 2022 by Sam Sihvonen, Kerkko Visuri, and Timo Moilanen, is a biotechnology company headquartered in Helsinki, Finland, focusing on combating antibiotic resistance. Solu is building a bacterial DNA database for analyzing, monitoring, and controlling antibiotic-resistant bacteria. Its software makes it easier to understand, detect, and prevent the spread of antibiotic resistance and enables the development of new treatments targeting resistant bacteria.